NZ didnt make any money in the first half, but if some kind of recovery there was priced into FY25 that might be a negative. Not sure of the consensus, but obviously redeploying capital to a higher return is better in the long run for the company, if it has been judged a recovery there is not worth sticking around for.
re: regulatory issues, those are going to cost, be sure of that. Already millions in legal fees.
Ann: Strategic Update, page-3
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.033(2.63%) |
Mkt cap ! $260.4M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.27 | $1.23 | $286.0K | 229.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1057 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.28 | 226 | 1 |
View Market Depth
| Last trade - 11.15am 26/08/2024 (20 minute delay) ? |
| SVR (ASX) Chart |